Login / Signup

Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol.

Katie AndresenEmma CuttingDimitrios ApostolopoulosAmy H EvansLaura OakleyAlimu DayimuNikolaos DemirisKatherine BongaertsRobyn StaplesWendy GoodingDavid RubinszteinRoger A Barker
Published in: BMJ open (2024)
EudraCT-2021-000897-27, ISRCTN56240656.
Keyphrases
  • phase ii
  • open label
  • phase iii
  • clinical trial
  • phase ii study
  • study protocol
  • placebo controlled
  • double blind
  • randomized controlled trial
  • endoplasmic reticulum stress
  • locally advanced